|
BIIB's Net Income Growth by Quarter and Year
Biogen Inc 's Net Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| BIIB Net Income (in millions $) |
FY 2024 |
FY 2023 |
FY 2022 |
FY 2021 |
| IV Quarter |
December |
-
|
248.90
|
549.50
|
-20.60
|
| III Quarter |
September |
-
|
-68.30
|
1,134.90
|
318.10
|
| II Quarter |
June |
583.60
|
593.30
|
1,058.70
|
1,025.50
|
| I Quarter |
March |
393.40
|
387.60
|
218.50
|
404.60
|
| FY |
|
977.00
|
1,161.50
|
2,961.60
|
1,727.60
|
| BIIB Net Income second quarter 2024 Y/Y Growth Comment |
Biogen Inc reported decrease in Net Income in the second quarter 2024 by -1.63% to $ 583.60 millions, from the same quarter in 2023.
The decrease in the second quarter 2024 Biogen Inc 's Net Income compares unfavorably to the Company's average Net Income jump of 48.06%.
According to the results reported in the second quarter 2024, Biogen Inc achieved the best Net Income growth in Biotechnology & Pharmaceuticals industry. While Biogen Inc ' s Net Income decline of -1.63% ranks overall at the positon no. 480 in the second quarter 2024.
|
| BIIB Net Income ( Y/Y Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
-54.7 % |
- |
- |
| III Quarter |
September |
- |
- |
256.77 % |
-54.81 % |
| II Quarter |
June |
-1.63 % |
-43.96 % |
3.24 % |
-36.17 % |
| I Quarter |
March |
1.5 % |
77.39 % |
-46 % |
-70.95 % |
| FY |
|
- |
-60.78 % |
71.43 % |
-57.45 % |
BIIB Net Income (Quarter on Quarter Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
- |
-51.58 % |
- |
| III Quarter |
September |
- |
- |
7.2 % |
-68.98 % |
| II Quarter |
June |
48.35 % |
53.07 % |
384.53 % |
153.46 % |
| I Quarter |
March |
58.06 % |
-29.46 % |
- |
13.17 % |
| FY (Year on Year) |
|
- |
-60.78 % |
71.43 % |
-57.45 % |
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 1560.25 % |
48.06 % |
-75.52 % |
| (June 30. 2007) |
|
(June 30. 2006) |
|
|
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 1560.25 % |
48.06 % |
-75.52 % |
| (June 30. 2007) |
|
(June 30. 2006) |
|
| Net Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024 |
Biogen Inc 's Q/Q Net Income Growth
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 4345.95 % |
75.62 % |
-68.98 % |
| (Sep. 30, 2004) |
|
|
| BIIB's II. Quarter Q/Q Net Income Comment |
Biogen Inc achieved in the II. Quarter 2024 below company average Net Income jump of 48.35% quarter on quarter, to $ 583.60 millions.
Within Biotechnology & Pharmaceuticals industry only one company achieved higher sequential Net Income growth. While Biogen Inc 's Net Income growth quarter on quarter, overall rank is 164. |
|
|
|
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 4345.95 % |
75.62 % |
-68.98 % |
| (Sep. 30, 2004) |
|
|
| BIIB's II. Quarter Q/Q Net Income Comment |
Biogen Inc achieved in the II. Quarter 2024 below company average Net Income jump of 48.35% quarter on quarter, to $ 583.60 millions.
Within Biotechnology & Pharmaceuticals industry only one company achieved higher sequential Net Income growth. While Biogen Inc 's Net Income growth quarter on quarter, overall rank is 164. |
|
Biogen Inc 's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
12 Months Ending
(Dec 31 2023) |
12 Months Ending
(Sep 30 2023) |
12 Months Ending
(Jun 30 2023) |
| Cumulative Net Income 12 Months Ending |
$ 1,157.60 |
$ 1,167.30 |
$ 1,161.50 |
$ 1,462.10 |
$ 2,665.30 |
| Y / Y Net Income Growth (TTM) |
-56.57 % |
-62.71 % |
-60.78 % |
-38.86 % |
69.26 % |
| Year on Year Net Income Growth Overall
Ranking |
# 224 |
# 7 |
# 81 |
# 528 |
# 1427 |
| Seqeuential Net Income Change (TTM) |
-0.83 % |
0.5 % |
-20.56 % |
-45.14 % |
-14.87 % |
| Seq. Net Income Growth (TTM) Overall
Ranking |
# 480 |
# 62 |
# 165 |
# 346 |
# 875 |
| Cumulative Net Income growth
Comment |
Biogen Inc showed decline, but improvement compare to trailing twelve month Net Income decrease in Mar 31 2024. If the fiscal year would end in Jun 30 2024, Biogen Inc 's annual Net Income fall would be -56.57% year on year to $1,158 millions.
Within the Healthcare sector 21 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 7 to 224. |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
1560.25 % |
48.06 % |
-75.52 % |
|
|
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
1560.25 % |
48.06 % |
-75.52 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 1 |
| Sector |
# 31 |
| S&P 500 |
# 480 |
|
| Cumulative Net Income growth
Comment |
Biogen Inc showed decline, but improvement compare to trailing twelve month Net Income decrease in Mar 31 2024. If the fiscal year would end in Jun 30 2024, Biogen Inc 's annual Net Income drop would be -56.57% year on year to $1,158 millions.
Within the Healthcare sector 21 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 7 to 224. |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
1560.25 % |
48.06 % |
-75.52 % |
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
1560.25 % |
48.06 % |
-75.52 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 1 |
| Sector |
# 31 |
| S&P 500 |
# 480 |
|
